Page last updated: 2024-11-06

mitomycin and Angioimmunoblastic Lymphadenopathy

mitomycin has been researched along with Angioimmunoblastic Lymphadenopathy in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsuji, M1
Itoh, Y1
Fukada, H1
Mori, H1
Sugimori, K1
Ohyabu, H1
Kageyama, T1

Other Studies

1 other study available for mitomycin and Angioimmunoblastic Lymphadenopathy

ArticleYear
[An autopsy study of immunoblastic lymphadenopathy (IBL)-like T-cell lymphoma in a patient previously treated with chemotherapy in colon cancer].
    Gan no rinsho. Japan journal of cancer clinics, 1989, Volume: 35, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy;

1989